The Blood Contribution to Early Myocardial Reperfusion Injury Is Amplified in Diabetes

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Diabetes

• Publication date

  1997-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/diab.46.11.1859PMID 9356037
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CD18 antibody treatment limits early myocardial reperfusion injury after initial leukocyte deposition.

  1996cited by this paper
• Pentoxifylline reduces leukocyte retention in the coronary microcirculation early in reperfusion following ischemia.

  1996cited by this paper
• Early in Reperfusion Following Myocardial Ischemia, Leukocyte Activation Is Necessary for Venular Adhesion But Not Capillary Retention

  1995cited by this paper
• Leukocyte-capillary plugging and network resistance are increased in skeletal muscle of rats with streptozotocin-induced hyperglycemia.

  1994cited by this paper
• Brief perfusion with diluted whole blood after global myocardial ischaemia increases reperfusion injury.

  1994influential reference
• Microvascular compression during myocardial ischemia: mechanistic basis for no-reflow phenomenon.

  1994cited by this paper
• Decreased Polymorphonuclear Leukocyte Deformability in NIDDM

  1994cited by this paper
• Antiischemic effects of nifedipine in isolated working heart preparations of healthy, diabetic, and hypertensive rats.

  1994cited by this paper
• Platelets do not modulate leukocyte-mediated coronary microvascular damage during early reperfusion.

  1994cited by this paper
• Insulin Stimulates the Polymorphonuclear Leukocyte Chemokinesis

  1993cited by this paper
• Streptozotocin-induced non-insulin-dependent diabetes protects the heart from infarction.

  1993cited by this paper
• Flow cytometric determination of CD11b upregulation in vivo.

  1993cited by this paper
• Pharmacokinetics of 70-kilodalton fluorescein-dextran in experimental diabetes mellitus.

  1993cited by this paper
• Production of hydrogen peroxide by neutrophilic polymorphonuclear leukocytes in patients with diabetic nephropathy

  1993cited by this paper
• Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial

  1993cited by this paper
• Enhanced superoxide radical production by stimulated polymorphonuclear leukocytes in a cat model of diabetes.

  1992cited by this paper
• Diabetes and susceptibility to reperfusion-induced ventricular arrhythmias.

  1992cited by this paper
• Expression of functional antigens on neutrophils. Effects of preparation.

  1992cited by this paper
• Detection of granulocyte reactive oxygen species formation in whole blood using flow cytometry.

  1992cited by this paper
• Direct Vital Microscopic Study of Defective Leukocyte-Endothelial Interaction in Diabetes Mellitus

  1991cited by this paper
• Decreased expression of adhesion molecules on monocytes in recent onset IDDM.

  1991cited by this paper
• Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy.

  1991cited by this paper
• Disposition of fluorescein-labelled dextran (150 kD) in isolated perfused livers from control and diabetic rats.

  1991cited by this paper
• Respiratory burst in alveolar macrophages of diabetic rats.

  1990cited by this paper
• Na(+)-H+ exchange in cardiac sarcolemmal vesicles isolated from diabetic rats.

  1990cited by this paper
• Early in reperfusion, leukocytes alter perfused coronary capillarity and vascular resistance.

  1989cited by this paper
• The role of the neutrophil and free radicals in ischemic myocardial injury.

  1989cited by this paper
• Peripheral vascular disease. Rheologic variables during controlled ischemia.

  1989cited by this paper
• The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study.

  1988cited by this paper
• Hearts From Diabetic Rats Are More Resistant to In Vitro Ischemia: Possible Role of Altered Ca2+ Metabolism

  1988cited by this paper
• Alterations in cardiac sarcolemmal Ca2+ pump activity during diabetes mellitus.

  1987cited by this paper
• Increased adhesion to fibronectin and Mo-1 expression by diabetic monocytes.

  1987cited by this paper
• Sarcolemmal Ca2+ transport in streptozotocin-induced diabetic cardiomyopathy in rats.

  1987cited by this paper
• Decreased deformability of erythrocytes in hyperglycaemic non-inbred ob/ob mice

  1986cited by this paper
• Altered Red and White Blood Cell Rheology in Type II Diabetes

  1986cited by this paper
• Oxygen-derived free radicals in postischemic tissue injury.

  1985cited by this paper
• Size of acute myocardial infarcts in patients with diabetes mellitus.

  1985cited by this paper
• Direct visualization of the coronary microcirculation for pharmacologic and physiologic studies.

  1984cited by this paper
• Nonenzymatic glucosylation of homologous low density lipoprotein and albumin renders them immunogenic in the guinea pig.

  1983cited by this paper
• Chemiluminescence and superoxide anion production by leukocytes from diabetic patients.

  1983cited by this paper
• Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation.

  1983cited by this paper
• Both protein and blood cells reduce coronary microvascular permeability to macromolecules.

  1983cited by this paper
• The Effect of Diabetes on Performance and Metabolism of Rat Hearts

  1980cited by this paper
• Effects of Ischemia on Rat Myocardial Function and Metabolism in Diabetes

  1979cited by this paper
• Diabetes and cardiovascular disease. The Framingham study.

  1979cited by this paper
• Diabetes and the survival and recovery of the anoxic myocardium.

  1975cited by this paper
• Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus.

  1971cited by this paper

• Acute Hyperglycemia-Induced Injury in Myocardial Infarction

  2024cites this paper
• Risk Factors for No-Reflow in Patients with ST-Elevation Myocardial Infarction Who Underwent Percutaneous Coronary Intervention: A Case-Control Study

  2022cites this paper
• Myocardial Infarction and Acute Coronary Syndromes Association Between Hyperglycemia and the No-Reflow Phenomenon in Patients With Acute Myocardial Infarction

  2016cites this paper
• Thrombolytic Effect of Streptokinase Infusion Assessed by ST Segment Resolution between Diabetic and Non Diabetic Myocardial Infarction Patients

  2015cites this paper
• FMLP-, thapsigargin-, and H2O2-evoked changes in intracellular free calcium concentration in lymphocytes and neutrophils of type 2 diabetic patients

  2014cites this paper
• Clenbuterol plus granulocyte colony-stimulating factor regulates stem/progenitor cell mobilization and exerts beneficial effect by increasing neovascularization in rats with heart failure.

  2013cites this paper
• Presence of Metabolic Syndrome is not an Independent Predictor of In-hospital Adverse Events in Patients with ST Elevation Myocardial Infarction that Underwent Primary Percutaneous Coronary Intervention

  2013cites this paper
• Impact of Diabetic Mellitus on the Effect of Streptokinase in Acute Myocardial Infarction Patients

  2013cites this paper
• Risk factors and blood-borne biochemical markers in type 2 diabetes mellitus

  2012cites this paper
• Cardioprotective actions of two bioflavonoids, quercetin and rutin, in experimental myocardial infarction in both normal and streptozotocin‐induced type I diabetic rats

  2009cites this paper
• Cardioprotective actions of two bioflavonoids , quercetin and rutin , in experimental myocardial infarction in both normal and streptozotocin-induced type I diabetic rats

  2009cites this paper
• Cardiac ischemia and reperfusion in spontaneously diabetic rats with and without application of EGb 761: II. Interstitium and microvasculature.

  2009cites this paper
• A comparative study on the effect of streptokinase between diabetic and non-diabetic myocardial infarction patients

  2008cites this paper
• Complement inhibition reduces injury in the type 2 diabetic heart following ischemia and reperfusion.

  2008cites this paper
• A comparative study on the effect of streptokinase between diabetic and non-diabetic myocardial infarction patients 1

  2008cites this paper
• The Role of Complement in Ischemic Heart Disease in Type 2 Diabetes Mellitus

  2008cites this paper
• The role of adiponectin in ischemia -reperfusion injury in the type 2 diabetic heart

  2008influential citation
• Inflammatory and Hemodynamic Changes in the Cerebral Microcirculation of Aged Rats after Global Cerebral Ischemia and Reperfusion

  2008cites this paper
• Comparison of sample fixation and the use of LDS-751 or anti-CD45 for leukocyte identification in mouse whole blood for flow cytometry.

  2007cites this paper
• The effect of metabolic syndrome on the development of major adverse cardiac events in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction with ST-segment elevation

  2007cites this paper
• EFFECTS OF OBESITY AND TYPE 2 DIABETES ON MOUSE PLATELET AND PMN LEUKOCYTE MARKERS OF ACTIVATION

  2006cites this paper
• Leukocyte-Platelet Aggregates in Rat Peripheral Blood After Ischemic Stroke and Reperfusion

  2005influential citation
• Type 2 diabetes and intravenous thrombolysis outcome in the setting of ST elevation myocardial infarction.

  2004cites this paper
• Increasing neutrophil F‐actin corrects CD11b exposure in Type 2 diabetes

  2004cites this paper
• The effect of methylprednisolone treatment on the cardiopulmonary bypass-induced systemic inflammatory response.

  2004cites this paper
• Impaired neutrophil store‐mediated calcium entry in Type 2 diabetes

  2004cites this paper
• Onset of diabetes in Zucker diabetic fatty (ZDF) rats leads to improved recovery of function after ischemia in the isolated perfused heart.

  2004cites this paper
• Chronic expression of platelet adhesion proteins is associated with severe ischemic heart disease in type 2 diabetic patients: Chronic platelet activation in diabetic heart patients.

  2003cites this paper
• Eating disorders in 12- to 16-year-old diabetic and nondiabetic adolescents from Barcelona, Spain.

  2003cites this paper
• Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction.

  2003cites this paper
• Diabetes mellitus is associated with insufficient microvascular reperfusion following revascularization for anterior acute myocardial infarction.

  2003cites this paper
• Effect of Hyperglycemia and Nitric Oxide Synthase Inhibition on Heat Tolerance and Induction of Heat Shock Protein 72 κDa in Vivo

  2003cites this paper
• Haptoglobin type and 30-day mortality in diabetic individuals presenting with acute myocardial infarction.

  2003cites this paper
• Molecular Basis for Microcirculatory Disorders

  2003cites this paper
• Microvascular Pathobiology in Diabetes

  2003cites this paper
• THE CONTRIBUTION OF BLOOD COMPONENTS TO MYOCARDIAL ISCHEMIA REPERFUSION INJURY AND THE BENEFITS OF VITAMIN E IN THE DIABETIC HEART

  2003influential citation
• INFLAMMATION IN DIABETIC WOMEN WITH CARDIOVASCULAR DISEASE

  2003cites this paper
• MECHANISMS OF PLATELET ACTIVATION IN TYPE 2 DIABETES

  2003influential citation
• Impaired neutrophil actin assembly causes persistent CD11b expression and reduced primary granule exocytosis in Type II diabetes

  2002cites this paper
• In Vivo Observation of the Blood Flow in Human Capillaries under Finger Nailfold

  2002cites this paper
• Hyperglycemia reduces coronary collateral blood flow through a nitric oxide-mediated mechanism.

  2001cites this paper
• Microvascular Perfusion and Transport in the Diabetic Heart

  2000cites this paper
• Diabetes enhances leukocyte accumulation in the coronary microcirculation early in reperfusion following ischemia.

  2000cites this paper
• Reperfusion injury is not affected by blockade of P-selectin in the diabetic mouse heart.

  1999cites this paper
• Reperfusion injury is not affected by blockade of P-selectin in the diabetic mouse heart.

  1999cites this paper
• Reperfusion‐induced oxidative stress in diabetes: cellular and enzymatic sources

  1999cites this paper
• Possible risk of sulphonylureas in the treatment of non-insulin-dependent diabetes mellitus and coronary artery disease

  1998cites this paper
• Possible risk of sulphonylureas in the treatment of non-insulin-dependent diabetes mellitus and coronary artery disease

  1998cites this paper
• Simple clinical risk score for no-reflow prediction in patients undergoing primary Percutaneous Coronary Intervention with acute STEMI

  1969cites this paper